Jin Y - Search Results

1

A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy.

Yi K, Kong H, Zheng C, Zhuo C, Jin Y, Zhong Q, Mintz RL, Ju E, Wang H, Lv S, Lao YH, Tao Y, Li M. Yi K, et al. Among authors: jin y. Biomaterials. 2023 Nov;302:122349. doi: 10.1016/j.biomaterials.2023.122349. Epub 2023 Oct 6. Biomaterials. 2023. PMID: 37844429

2

3D Printed Bioceramic Scaffolds as a Universal Therapeutic Platform for Synergistic Therapy of Osteosarcoma.

Dang W, Yi K, Ju E, Jin Y, Xu Y, Wang H, Chen WC, Wang K, Wang Y, Tao Y, Li M. Dang W, et al. Among authors: jin y. ACS Appl Mater Interfaces. 2021 Apr 28;13(16):18488-18499. doi: 10.1021/acsami.1c00553. Epub 2021 Apr 15. ACS Appl Mater Interfaces. 2021. PMID: 33856761

3

Multifunctional hybrid sponge for in situ postoperative management to inhibit tumor recurrence.

Wang H, Jin Y, Chen Y, Luo Y, Lv S, Li M, Tao Y. Wang H, et al. Among authors: jin y. Biomater Sci. 2021 Jun 4;9(11):4066-4075. doi: 10.1039/d1bm00085c. Biomater Sci. 2021. PMID: 33908452

4

Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure.

Jin Y, Wang H, Yi K, Lv S, Hu H, Li M, Tao Y. Jin Y, et al. Nanomicro Lett. 2020 Nov 19;13(1):25. doi: 10.1007/s40820-020-00550-x. Nanomicro Lett. 2020. PMID: 34138224 Free PMC article. Review.

5

Stem cell-derived hepatocyte therapy using versatile biomimetic nanozyme incorporated nanofiber-reinforced decellularized extracellular matrix hydrogels for the treatment of acute liver failure.

Jin Y, Zhang J, Xu Y, Yi K, Li F, Zhou H, Wang H, Chan HF, Lao YH, Lv S, Tao Y, Li M. Jin Y, et al. Bioact Mater. 2023 May 18;28:112-131. doi: 10.1016/j.bioactmat.2023.05.001. eCollection 2023 Oct. Bioact Mater. 2023. PMID: 37250866 Free PMC article.

6

Multimodal Tetrahedral DNA Nanoplatform for Surprisingly Rapid and Significant Treatment of Acute Liver Failure.

Wei H, Yi K, Li F, Li D, Yang J, Shi R, Jin Y, Wang H, Ding J, Tao Y, Li M. Wei H, et al. Among authors: jin y. Adv Mater. 2024 Jul;36(30):e2305826. doi: 10.1002/adma.202305826. Epub 2024 Apr 23. Adv Mater. 2024. PMID: 37801371

7

Microfluidic Fabrication of MicroRNA-Induced Hepatocyte-Like Cells/Human Umbilical Vein Endothelial Cells-Laden Microgels for Acute Liver Failure Treatment.

Li F, Wei H, Jin Y, Xue T, Xu Y, Wang H, Ju E, Tao Y, Li M. Li F, et al. Among authors: jin y. ACS Nano. 2023 Dec 26;17(24):25243-25256. doi: 10.1021/acsnano.3c08495. Epub 2023 Dec 8. ACS Nano. 2023. PMID: 38063365

8

3D printing incorporating gold nanozymes with mesenchymal stem cell-derived hepatic spheroids for acute liver failure treatment.

Jin Y, Zhang J, Chen X, Li F, Xue T, Yi K, Xu Y, Wang H, Lao YH, Chan HF, Shao D, Li M, Tao Y. Jin Y, et al. Biomaterials. 2025 Apr;315:122895. doi: 10.1016/j.biomaterials.2024.122895. Epub 2024 Oct 19. Biomaterials. 2025. PMID: 39461063

9

Chemoradiotherapy combined with NK cell transfer in a patient with recurrent and metastatic nasopharyngeal carcinoma inducing long-term tumor control: A case report.

Jin YY, Yang WZ, Zou S, Sun ZY, Wu CT, Yang ZY. Jin YY, et al. Medicine (Baltimore). 2020 Oct 23;99(43):e22785. doi: 10.1097/MD.0000000000022785. Medicine (Baltimore). 2020. PMID: 33120792 Free PMC article.

10

Reduced plasma cortistatin is related to clinical parameters in patients with essential hypertension.

Chen W, Fu Y, Jin Y, Zheng W, Liu Y. Chen W, et al. Among authors: jin y. Peptides. 2024 Jul;177:171225. doi: 10.1016/j.peptides.2024.171225. Epub 2024 Apr 18. Peptides. 2024. PMID: 38642617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,710 results

Search Page

Filters